Nintoin Suspension (Nitrofurantoin 25/5mg/ml) is a bactericidal antibiotic that helps to treat or prevent urinary tract infections. It should be used with caution in patients with kidney disease.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Avoid consumption of alcohol while taking Nintoin Suspension because it might make you dizzier.
Nintoin Suspension can be used during pregnancy only if prescribed by your doctor. It should, however, not be used at this stage of pregnancy (during labor or delivery) as it may harm the unborn baby. It is essential to always consult a doctor before starting any medicine during pregnancy.
As Nintoin Suspension is known to pass into breast milk, you should consult your doctor before using this medicine during breastfeeding.
Nintoin Suspension may cause dizziness and drowsiness, hence you need to be cautious while driving.
Nintoin Suspension is not recommended for use in patients with kidney disease that severely affects the function of the kidneys. It should be used with caution in patients with kidney problems. Consult your doctor before taking Nintoin Suspension
Nintoin Suspension should be taken with caution in patients with liver disease. Consult your doctor before taking Nintoin Suspension
Nintoin Suspension effectively treats and prevents urinary tract infections by killing bacteria present in the urethra, bladder, and/or kidneys. It mainly acts by disrupting the production of genetic material present in the bacterial cell.
Nintoin Suspension is an antibiotic medicine. It is used for the treatment and prevention of uncomplicated urinary tract infections.
Nitrofurantoin is an antibacterial agent that works particularly well for infections of the urinary tract. Extremely solvent in urination, nitrofurantoin may give poop a brown hue. Ribosomal proteins and other macromolecules produced by bacteria are inactivated or altered by nitrofurantoin. It has been demonstrated that nitrofurantoin is effective against pursuing microscopic organisms: Grass-Feeding Aerobes Enterococcus faecalis, Staphylococcus aureus, Streptococcus agalactiae, Gather D streptococci, and Viridans gather streptococci are among the staphylococci that are Coagulase-negative and include Staphylococcus epidermidis. Escherichia coli, Citrobacter amalonaticus, Citrobacter diversus, Citrobacter freundii, Klebsiella oxytoca, and Klebsiella ozaena are examples of Gram-negative Aerobes.
The recommended dosage of Nitrofurantoin suspension for children is 5-7 mg/kg/day, divided into four doses per day. However, it is contraindicated for use in infants under one month of age. The average doses for pediatric patients are as follows:
Treatment should be continued for one week or at least 3 days after the urine becomes sterile. In some cases, for long-term suppressive therapy in children, lower doses of 1 mg/kg per 24 hours may be sufficient. This dose can be given as a single dose or divided into two doses.
Always take Bevon Suspension as advised by the physician. Shake well before use. Do not exceed the recommended daily dosage. Use a measuring cup or a spoon to properly measure the dose. Do not take Bevon Suspension if you are allergic to any of its components.
When Nitrofurantoin is taken together with antacids containing Magnesium Trisilicate, it can interfere with the absorption and effectiveness of certain uricosuric medicines, such as Probenecid and Sulfinpyrazone. Uricosuric medicines are used to treat conditions like gout by increasing the excretion of uric acid from the body.
The presence of Magnesium Trisilicate in antacids can reduce the absorption rate and extent of these uricosuric medicines, making them less effective in lowering uric acid levels. Additionally, Nitrofurantoin can also be affected by the interaction with Magnesium Trisilicate, as it can limit the secretion of Nitrofurantoin in the renal tubules (part of the kidney involved in urine formation and excretion).
To ensure the optimal effectiveness of both Nitrofurantoin and uricosuric medicines, it is advisable to separate their administration. It is recommended to take Nitrofurantoin and uricosuric medicines at different times, with an appropriate time interval between them. This helps to avoid any potential interactions and allows for proper absorption and effectiveness of each medication.
Pregnancy Category B. Limited and inconclusive studies have been conducted on the use of this medication in pregnant women. It should only be used during pregnancy if it is absolutely necessary. Small amounts of nitrofurantoin have been detected in human breast milk. Considering the potential for significant side effects in nursing infants under one month old, a decision should be made regarding whether to discontinue breastfeeding or discontinue the medication, taking into account the importance of the drug to the mother.
In elderly patients, caution should be exercised when using Nitrofurantoin. It is important to monitor hepatic (related to the liver) and pulmonary (related to the lungs) function during prolonged therapy to ensure the medication is well-tolerated and does not cause any adverse effects.
If a patient has pre-existing pulmonary, hepatic, neurological, or allergic disorders or a predisposition to peripheral neuropathy (damage to the nerves in the extremities), special care should be taken when considering the use of Nitrofurantoin. This includes individuals with conditions such as renal impairment (kidney dysfunction), anemia, diabetes mellitus (high blood sugar), electrolyte imbalance, debility (weakness), and vitamin B deficiency.
If signs of peripheral neuropathy, such as numbness, tingling, or pain in the hands or feet, occur during treatment with Nitrofurantoin, the medication should be discontinued.
Regarding lactation, Nitrofurantoin enters breast milk. Therefore, it is recommended to discontinue the drug or avoid nursing while taking Nitrofurantoin to prevent potentially adverse effects on the breastfed infant.
Do not store above 30°C. Keep away from light and out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.